Osteoporosis management in the new millennium.

Gina S Wei, Jeffrey L Jackson, Christos Hatzigeorgiou, Jeanne K Tofferi

Journal: Primary care 2004;30(4):711-41, vi-vii

PMID: 15024893

Full Text on Elsevier Science View on PubMed

Abstract

The prevalence of osteoporosis in all US postmenopausal women is 17%, and it is as high as 30% in women older than 65. All postmenopausal women should be encouraged to have adequate daily calcium and vitamin D intake, to exercise regularly, and to avoid tobacco and excessive alcohol use. Although the clinical impact and cost-effectiveness of osteoporosis screening tools remain to be established, a rational approach based on current evidence involves using National Osteoporosis Foundation guidelines, Simple Calculated Osteoporosis Risk Estimation, or Osteoporosis Risk Assessment Instrument clinical decision rules to decide when a postmenopausal woman should undergo further evaluation.

Address: Department of Medicine, Uniformed Services University of Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. [email protected]

DOI: 10.1016/s0095-4543(03)00090-3

Link outs

Subscription / membership required

Full Text Sources:

MeSH Terms: Alendronate, Bone Density, Calcitonin, Calcium, Estrogens, Etidronic Acid, Exercise, Humans, Middle Aged, Osteoporosis, Postmenopausal, Raloxifene Hydrochloride, Risedronic Acid